News
CRIS
14.69
-0.54%
-0.08
Weekly Report: what happened at CRIS last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at CRIS last week (0408-0412)?
Weekly Report · 04/15 12:13
Top 3 Health Care Stocks That May Collapse In Q2
Three stocks in the health care sector are overbought as of April 12, 2024. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength when they go down. An asset is typically considered to be overb bought when the RSI value is above 70.
Benzinga · 04/12 12:34
Weekly Report: what happened at CRIS last week (0401-0405)?
Weekly Report · 04/08 12:19
Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?
NASDAQ · 04/05 12:43
12 Health Care Stocks Moving In Thursday's Intraday Session
Candel Therapeutics (NASDAQ:CADL) shares moved upwards by 64.3% to $2.76 during Thursday's regular session. Macrogenics ( NASDAQ:MGNX) stock rose 32.55% during the session. Barinthus Biotherapeutics shares increased by 29.55%.
Benzinga · 04/04 16:31
Weekly Report: what happened at CRIS last week (0325-0329)?
Weekly Report · 04/01 12:15
Weekly Report: what happened at CRIS last week (0318-0322)?
Weekly Report · 03/25 12:19
Weekly Report: what happened at CRIS last week (0311-0315)?
Weekly Report · 03/18 12:17
Weekly Report: what happened at CRIS last week (0304-0308)?
Weekly Report · 03/11 12:12
Curis (CRIS) Gets a Buy from Truist Financial
TipRanks · 03/08 12:15
Weekly Report: what happened at CRIS last week (0226-0301)?
Weekly Report · 03/04 12:16
Weekly Report: what happened at CRIS last week (0219-0223)?
Weekly Report · 02/26 12:36
Weekly Report: what happened at CRIS last week (0212-0216)?
Weekly Report · 02/19 12:39
Weekly Report: what happened at CRIS last week (0205-0209)?
Weekly Report · 02/12 12:23
Curis Inc. Is Worried About This – Should You Be Worried Too?
TipRanks · 02/10 06:00
CyberArk Software To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Friday
Telsey Advisory Group raised the price target for Ralph Lauren Corporation from $165 to $195. HSBC cut Bunge Global SA's price target from $122 to $105. Inotiv shares jumped 16.8% to close at $4.30 on Thursday. Wells Fargo cut Everest Group, Ltd. Price target.
Benzinga · 02/09 13:11
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Curis (CRIS)
TipRanks · 02/09 13:10
Analysts Are Bullish on Top Healthcare Stocks: Foghorn Therapeutics (FHTX), Sensus Healthcare (SRTS)
TipRanks · 02/09 11:20
Curis Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 02/09 11:18
More
Webull provides a variety of real-time CRIS stock news. You can receive the latest news about Curis through multiple platforms. This information may help you make smarter investment decisions.
About CRIS
Curis, Inc. is a biotechnology company. The Company is focused on the development of emavusertib (CA-4948), an orally available, small molecule inhibitor of Interleukin-1 receptor associated kinase (IRAK4). Emavusertib is undergoing testing in the Phase I/II TakeAim Lymphoma study in patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the Phase I/II TakeAim Leukemia study in patients with relapsed/refractory acute myeloid leukemia (AML) and relapsed/refractory high risk myelodysplastic syndrome (hrMDS). Its other clinical programs include Fimepinostat and CA-170. Fimepinostat is an oral, dual inhibitor of histone deacetylase (HDAC), and phosphotidyl-inositol 3 kinase (PI3K) enzymes. CA-170 is an oral small molecule drug candidate that is designed to selectively target V-domain Ig Suppressor of T-cell Activation (VISTA) and PDL1 immune checkpoint proteins.